Visit | Screening visit (V0) | Baseline (V1) | V2† (1 month±7 days) | V3† (3 months±7 days) | V4† (6 months±7 days) | V5 (9 months±15 days) | V6 (date of V5+7 days) |
Information | X | ||||||
Written consent | X | ||||||
Inclusion and non-inclusion criteria | X | ||||||
Clinical assessment | X | X | |||||
Vital signs | X | X | |||||
Anthropometric measures | X | X | |||||
Blood samples | X | X | |||||
PCDAI/PUCAI* | X | X | |||||
Bone age | X | X | |||||
Bone mineral density | X | X | |||||
Concomitant treatments | X | X | |||||
Quality of life/fatigue score | X | X | |||||
AE and SAE* | X | X | X | X | X | ||
Randomisation | X | ||||||
Physical activity | X | X | |||||
Dietary assessment | X | X | |||||
Phone call | X | X | X | X |
AE, adverse event; PCDAI, Pediatric Crohn’s Disease Activity Index; PUCAI, Pediatric Ulcerative Colitis Disease Activity Index; SAE, serious adverse event.